» Authors » Davide Vagnoni

Davide Vagnoni

Explore the profile of Davide Vagnoni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 45
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Galieni P, Travaglini F, Vagnoni D, Ruggieri M, Caraffa P, Bigazzi C, et al.
Br J Haematol . 2021 Apr; 193(3):542-550. PMID: 33792026
The Revised International Staging System (R-ISS) stratifies patients affected by Multiple Myeloma (MM) into three distinct risk groups: R-ISS I [ISS Stage I, Standard-Risk cytogenetics and normal Lactase DeHydrogenase (LDH)],...
2.
Rocco V, Castelli C, Fumi M, Mancini F, Pancione Y, Prisciandaro M, et al.
Int J Lab Hematol . 2018 Oct; 41(1):124-132. PMID: 30358123
Introduction: Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia (AML) with a life-threatening coagulopathy. Once it is suspected, ATRA should be started. Appreciation of APL details is...
3.
Vagnoni D, Travaglini F, Pezzoni V, Ruggieri M, Bigazzi C, Dalsass A, et al.
Br J Haematol . 2015 May; 170(4):523-31. PMID: 26010293
Detection of circulating plasma cells (PCs) in multiple myeloma (MM) patients is a well-known prognostic factor. We evaluated circulating PCs by flow cytometry (FC) in 104 patients with active MM...
4.
Dalsass A, Mestichelli F, Ruggieri M, Gaspari P, Pezzoni V, Vagnoni D, et al.
Eur J Haematol . 2013 Apr; 91(1):10-9. PMID: 23560441
Deletions of the long arm of chromosome 6 are known to occur at relatively low frequency (3-6%) in chronic lymphocytic leukemia (CLL), and they are more frequently observed in 6q21....